1-7 of 7
Dietmar Pils
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer

Anna Bachmayr-Heyda, Stefanie Aust, Katharina Auer, Samuel M. Meier, Klaus G. Schmetterer, Sabine Dekan, Christopher Gerner, Dietmar Pils
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (8): 2081–2092.
https://doi.org/10.1158/1078-0432.CCR-16-1647
Published: 13 April 2017
View articletitled, Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer
Open the PDF for Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B56: Peritoneal tumor spread in high grade serous ovarian cancer: An effect of the competing endogenous RNA network?

Anna Bachmayr-Heyda, Katharina Auer, Nyamdelger Sukhbaatar, Stefanie Aust, Simon Deycmar, Agnes T. Reiner, Stephan Polterauer, Sabine Dekan, Dietmar Pils
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): B56.
https://doi.org/10.1158/1557-3265.OVCA15-B56
Published: 15 January 2016
View articletitled, Abstract B56: Peritoneal tumor spread in high grade serous ovarian cancer: An effect of the competing endogenous RNA network?
Journal Articles

Abstract A78: Serum metabolomics, cytokine measurements, and tumor RNA-seq identified phospholipids correlated with a molecular subclass as strong predictor for outcome in high-grade serous ovarian cancer.

Stefanie Aust, Anna Bachmayr-Heyda, Katharina Auer, Nyamdelger Sukhbaatar, Samuel M. Meier, Christopher Gerner, Dietmar Pils
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A78.
https://doi.org/10.1158/1557-3265.OVCA15-A78
Published: 15 January 2016
View articletitled, Abstract A78: Serum metabolomics, cytokine measurements, and tumor RNA-seq identified phospholipids correlated with a molecular subclass as strong predictor for outcome in high-grade serous ovarian cancer.
Journal Articles

Abstract B55: Peritoneal tumor spread in high-grade serous ovarian cancer: Differences in the immune response.

Katharina Auer, Anna Bachmayr-Heyda, Nyamdelger Sukhbaatar, Stefanie Aust, Christoph Grimm, Reinhard Horvat, Dietmar Pils
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): B55.
https://doi.org/10.1158/1557-3265.OVCA15-B55
Published: 15 January 2016
View articletitled, Abstract B55: Peritoneal tumor spread in high-grade serous ovarian cancer: Differences in the immune response.
Journal Articles

Abstract B28: Validation of a combined 13 gene six protein blood signature for earlier detection of ovarian cancer.

Anna Bachmayr-Heyda, Stefanie Aust, Katharina Auer, Peter Borossay, Nina Pecha, Ugo Cavallaro, Ioana Braicu, Sarah Igidbashian, Costanza Savino, Franchi Dorella, Jalid Sehouli, Sonia Zaafrani, Florian Fitzal, Christian Singer, Michael Gnant, Robert Zeillinger, Dietmar Pils
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): B28.
https://doi.org/10.1158/1557-3265.OVCA15-B28
Published: 15 January 2016
View articletitled, Abstract B28: Validation of a combined 13 gene six protein blood signature for earlier detection of ovarian cancer.
Journal Articles

hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer

Michael Wittinger, Petr Vanhara, Ahmed El-Gazzar, Bettina Savarese-Brenner, Dietmar Pils, Mariam Anees, Thomas W. Grunt, Maria Sibilia, Martin Holcmann, Reinhard Horvat, Michael Schemper, Robert Zeillinger, Christian Schöfer, Helmut Dolznig, Peter Horak, Michael Krainer
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (24): 7816–7827.
https://doi.org/10.1158/1078-0432.CCR-11-0408
Published: 18 December 2011
View articletitled, hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer
Open the PDF for hVps37A Status Affects Prognosis and Cetuximab Sensitivity in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5

Peter Horak, Dietmar Pils, Alexandra Kaider, Alexander Pinter, Katarzyna Elandt, Cornelia Sax, Christoph C. Zielinski, Reinhard Horvat, Robert Zeillinger, Alexander Reinthaller, Michael Krainer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8585–8591.
https://doi.org/10.1158/1078-0432.CCR-05-1276
Published: 16 December 2005
View articletitled, Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5
Open the PDF for Perturbation of the Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Cascade in Ovarian Cancer: Overexpression of FLIPL and Deregulation of the Functional Receptors DR4 and DR5 in another window